Dr. Karas is an associate director of global development at Mind Medicine and functioned at the clinical lead for the first randomized placebo controlled trial of LSD in modern history. Dr. Karas obtained her doctorate at Pacific University in Clinical Psychology and went on to specialize in geriatric neuropsychology. Dr. Karas previously worked on phase 2 and 3 clinical trials in neurodegenerative disorders before finding her way into psychedelic clinical trials. Dr. Karas is passionate about the return of psychedelics to psychiatry to treat patients who are lacking efficacious treatment options. Dr. Karas hopes that with thoughtful experimental designs in psychedelic clinical trials, all patients will have access to affordable treatment options globally.